Section Arrow
GPCR.NASDAQ
- Structure Therapeutics
Quotes are at least 15-min delayed:2026/07/17 04:52 EDT
Pre Market
Last
 45
-1.03 (-2.24%)
Bid
45
Ask
56.35
High 45.99 
Low 44.83 
Volume 424 
Regular Hours (Closed)
Last
 46.03
-3.59 (-7.23%)
Day High 
49.455 
Prev. Close
49.62 
1-M High
57.0733 
Volume 
654.23K 
Bid
45
Ask
56.35
Day Low
45.97 
Open
49.455 
1-M Low
41.71 
Market Cap 
3.53B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 53.22 
20-SMA 50.36 
50-SMA 43.77 
52-W High 94.9 
52-W Low 15.8 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.64/-3.77
Enterprise Value
3.53B
Balance Sheet
Book Value Per Share
20.36
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
LIMNLiminatus Pharma Inc0.1477+0.0332+29.00%-- 
Pre Market 0.1291 -0.0186 -12.59%
ATAIAtaiBeckley Inc7.15+1.79+33.40%-- 
Pre Market 7.085 -0.065 -0.91%
KAPAKairos Pharma Ltd.0.3399+0.0219+6.89%-- 
Pre Market 0.295 -0.0449 -13.21%
RXRXRecursion Pharmaceuticals3.02-0.29-8.76%-- 
Pre Market 2.9505 -0.0695 -2.30%
IOVAIovance Biotherapeutics4.66-0.08-1.69%-- 
Pre Market 4.6235 -0.0365 -0.78%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leveragesboth structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable andoperating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.